Previous studies have revealed that the upregulation of CD81 could alleviate the LPS-induced injury in A549 cells, and the reduction of CD9/CD81 may be associated with the progression of inflammatory lung diseases, especially in COPD [29, 30]. Here, CD9 is linked to chronic obstructive pulmonary disease.